Healthcare
Wednesday, April 20, 2016
BRIEF-AmpliPhi Biosciences provides update on phage therapy Phase I trial
* AmpliPhi Biosciences provides update on Phase I trial:
phage therapy well tolerated in first cohort
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment